ONO PHARMACEUTICAL CO LTD innovation strategy

Patent filings in countries

#	Industry
#1	Pharmaceuticals
#2	Organic fine chemistry
#3	Biotechnology
#4	Environmental technology
#5	Macromolecular chemistry and polymers
#6	Micro-structure and nano-technology

#	Technology
#1	Therapeutic chemical compounds
#2	Medical preparations
#3	Heterocyclic compounds
#4	Acyclic or carbocyclic compounds
#5	Organic chemistry methods
#6	Peptides
#7	Climate change adaptation technologies
#8	Special acyclic compounds
#9	Polysaccharides
#10	Nanostructure applications

Publication	Filing date	Title
TW202102544A	2020-04-01	Bispecific antibody
TW202039485A	2019-11-29	Novel crystal of (3s)-3-[2-(6-amino-2-fluoropyridin-3-yl)-4-fluoro-1h-imidazol-5-yl]-7-[5-chloro-2-(1h-tetrazol-1-yl)phenyl]-2,3-dihydroindolizin-5(1h)-one
TW202028212A	2019-10-09	Sting agonist compound
AU2019341082A1	2019-09-19	DP antagonist
TW201942132A	2019-02-01	Bispecific antibody
TW201904580A	2018-06-27	Cancer recurrence and/or metastasis inhibitor
SG11201907240XA	2018-02-07	Compound having somatostatin receptor agonistic activity and pharmaceutical use thereof
SG11201906819VA	2018-01-25	Ethane-sulfonate salt of quinoline derivative
AU2017292522A1	2017-07-06	Combination comprising EP4 antagonist and immune checkpoint inhibitor
TW201733580A	2017-03-09	Treating agent for cancer having TrK inhibitor resistance
TW201629059A	2015-12-09	Dihydroindolizinone derivatives
AU2015202128A1	2015-04-24	Purinone derivative
AU2014325078A1	2014-09-29	Compound having agonistic activity to somatostatin receptor and medicinal use thereof
TW201542528A	2014-07-22	Quinoline derivative
AU2011274970A1	2011-07-05	Tetrahydrocarboline derivative
AU2006221364A1	2006-03-08	Particle and preparation containing the particle
AU2004220225A1	2004-03-12	Nitrogen-containing heterocyclic derivatives and drugs containing the same as the active ingredient
AU2003272879A1	2003-09-17	Triazaspiro[5.5]undecane derivatives and drugs comprising the same as the active ingredient